Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765] — Hossein Majidzadeh (2025) | RDL Network
Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765]
Corrigendum 2025 en
Authors
HM
Hossein Majidzadeh
MA
Mostafa Araj‐Khodaei
AA
Ayuob Aghanejad
Abstract
1 min read
[This corrects the article DOI: 10.1016/j.toxrep.2024.101765.].
Hossein Majidzadeh, Mostafa Araj‐Khodaei, Ayuob Aghanejad, Maryam Ghaffari, Amir Jafari, Forough Jenanifard, Ali Ezzati, Hashem Andishmand, Michael R Hamblin
Discussion(0)
No comments yet. Be the first to comment.